Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | RO7567132 |
| Trade Name | |
| Synonyms | RO 7567132|RO-7567132 |
| Drug Descriptions |
RO7567132 is a bispecific antibody targeting LTBR and FAP, which potentially induces expression of adhesion molecules, immune cell infiltration, and inhibition of tumor growth (Cancer Res (2025) 85 (8_Supplement_2): ND08). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + RO7567132 | Atezolizumab RO7567132 | 0 | 1 |
| RO7567132 | RO7567132 | 0 | 0 |